Clinical Trial Update: Efficacy and Safety of Green Tea Polyphenol in De Novo Parkinson's Disease Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated the efficacy and safety of a green tea polyphenol in de novo Parkinson's disease patients. The study sponsored by Xuanwu Hospital, Bei…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Green Tea Polyphenol

Snippet

Sponsor: Xuanwu Hospital, Beijing | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED